Carisma Therapeutics Inc. (NASDAQ: CARM)
$0.4080
-0.0099 ( -1.95% ) 75.0K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$0.4080
Previous close
$0.4179
Volume
75.0K
Market cap
$18.32M
Day range
$0.4070 - $0.4600
52 week range
$0.3809 - $3.1600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 68 | May 09, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 8 | Apr 29, 2024 |